Why the Middle East?
MENA Region Landscape
Pharma Business Size *
Biggest MKT (KSA 28%, EGY 21%, S.Afr 12% & UAE 9%).
FWA with fastest growth 16% PPG.
Rare & Orphan Diseases **
Est. globally there are 5000-8000 orphan disease that have been
identified with only 1500 identified includes (Sickle Cell Disease,
Thalassemia, Hemophilia, certain inborn errors of metabolism
(Pompe’s disease, Mucopolysaccharidosis types) and Bechet’s
disease.
EST. 2.97 Million patients in the MENA region
By 2025, MENA pharma market collectively to be US$ 56 B.
*IQVIA MENA market report Q1 2022
*IQVIA Orphan & Rare disease white paper 2019
*The Center of Arab Genomic Studies (CAGS)